Format

Send to

Choose Destination
See comment in PubMed Commons below
Treat Respir Med. 2004;3(1):29-34.

Epoprostenol in pregnant patients with secondary pulmonary hypertension: two case reports and a review of the literature.

Author information

1
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California, Davis Medical Center, Sacramento, California 95817, USA. mark.avdalovic@ucdmc.ucdavis.edu

Abstract

Women who present with pulmonary hypertension during gestation have traditionally been persuaded to terminate their pregnancy. Historically, the mortality associated with this group is very high. Certain patients with a secondary cause of pulmonary hypertension are believed to share similar pathophysiology with primary pulmonary hypertension patients. Recently, new treatments have become available that have slowed disease progression. We present the successful treatment of two patients who presented during late gestation with moderate pulmonary hypertension. Both patients were managed with intravenous vasodilators and anticoagulants without complication. Each patient successfully delivered a healthy child via spontaneous vaginal delivery. The review of the historical management of similar patients including new insights into the etiology of pulmonary arterial hypertension is also included. It highlights the complexity involved in managing such patients and the requirement of a multidisiplinary team approach.

PMID:
15174891
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center